Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002
Published online before print June 6, 2002, doi: 10.1161/01.RES.0000024412.24491.CA
A more recent version of this article appeared on July 12, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/1/38    most recent
01.RES.0000024412.24491.CAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jung, F.
Right arrow Articles by Dimmeler, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jung, F.
Right arrow Articles by Dimmeler, S.

Submitted on January 9, 2002
Revised on May 21, 2002
Accepted on May 22, 2002

Hypoxic Induction of the Hypoxia-Inducible Factor Is Mediated via the Adaptor Protein Shc in Endothelial Cells

Frank Jung ; Judith Haendeler ; Jörg Hoffmann ; Agnes Reissner ; Elisabeth Dernbach ; Andreas M. Zeiher ; and Stefanie Dimmeler *

From Molecular Cardiology, Department of Internal Medicine IV, University of Frankfurt, Frankfurt, Germany.

* To whom correspondence should be addressed. E-mail: Dimmeler{at}em.uni-frankfurt.de.

Tyrosine kinase cascades may play a role in the hypoxic regulation of hypoxia-inducible factor (HIF)-1. We investigated the role of tyrosine kinase phosphorylation and of the Shc/Ras cascade on hypoxic HIF-1 stabilization. Exposure of human umbilical vein endothelial cells to hypoxia results in HIF protein stabilization as early as 10 minutes, with a maximum at 3 hours, and also in Shc tyrosine phosphorylation, with a maximum at 10 minutes. To test whether Shc directly mediates hypoxia-induced HIF stabilization, human umbilical vein endothelial cells were transfected with a dominant-negative Shc mutant (dnShc), resulting in significantly reduced HIF protein levels compared with control. Similar results were obtained with cells transfected with dominant-negative Ras, a known downstream effector of Shc. Hypoxia-induced Ras activity was significantly reduced in cells transfected with dnShc compared with control levels, indicating that Ras indeed acts downstream from Shc. Moreover, cells pretreated with a specific Raf-1 kinase inhibitor, a known downstream effector of Ras, exhibited reduced HIF protein levels. To examine the functional consequences of Shc in hypoxic signaling, HIF-1 ubiquitination, protein stabilization, and endothelial cell migration were assessed. Overexpression of dnShc increased ubiquitination of HIF-1 and reduced the half-life of the protein. Moreover, dnShc, dominant-negative Ras, or the Raf-1 kinase inhibitor significantly inhibited migration under hypoxia. Thus, Shc in concert with Ras and Raf-1 contributes to hypoxia-induced HIF-1{alpha} protein stabilization and endothelial cell migration.


Key words: hypoxia • hypoxia-inducible factor-1 • Shc • Ras • endothelial cells




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G.-S. Hwang, S.-W. Wang, W.-M. Tseng, C.-H. Yu, and P. S. Wang
Effect of hypoxia on the release of vascular endothelial growth factor and testosterone in mouse TM3 Leydig cells
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1763 - E1769.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
A. M Abu El-Asrar, L. Missotten, and K. Geboes
Expression of hypoxia-inducible factor-1{alpha} and the protein products of its target genes in diabetic fibrovascular epiretinal membranes
Br. J. Ophthalmol., June 1, 2007; 91(6): 822 - 826.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Generali, A. Berruti, M. P. Brizzi, L. Campo, S. Bonardi, S. Wigfield, A. Bersiga, G. Allevi, M. Milani, S. Aguggini, et al.
Hypoxia-Inducible Factor-1{alpha} Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer
Clin. Cancer Res., August 1, 2006; 12(15): 4562 - 4568.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Sugiyama, T. Yoshimoto, K. Tsuchiya, N. Gochou, Y. Hirono, T. Tateno, N. Fukai, M. Shichiri, and Y. Hirata
Aldosterone Induces Angiotensin Converting Enzyme Gene Expression via a JAK2-Dependent Pathway in Rat Endothelial Cells
Endocrinology, September 1, 2005; 146(9): 3900 - 3906.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Yokoi and I. J. Fidler
Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine
Clin. Cancer Res., April 1, 2004; 10(7): 2299 - 2306.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Martin-Puig, E. Temes, G. Olmos, D. R. Jones, J. Aragones, and M. O. Landazuri
Role of Iron (II)-2-Oxoglutarate-dependent Dioxygenases in the Generation of Hypoxia-induced Phosphatidic Acid through HIF-1/2 and von Hippel-Lindau-independent Mechanisms
J. Biol. Chem., March 5, 2004; 279(10): 9504 - 9511.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. M. Conway, F. Zwerts, V. Van Eygen, A. DeVriese, N. Nagai, W. Luo, and D. Collen
Survivin-Dependent Angiogenesis in Ischemic Brain: Molecular Mechanisms of Hypoxia-Induced Up-Regulation
Am. J. Pathol., September 1, 2003; 163(3): 935 - 946.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J.-i. Abe and B. C. Berk
Hypoxia and HIF-1{alpha} Stability: Another Stress-Sensing Mechanism for Shc
Circ. Res., July 12, 2002; 91(1): 4 - 6.
[Full Text] [PDF]